LEBERS HEREDITARY OPTIC NEUROPATHY - NEW GENETIC CONSIDERATIONS

被引:202
作者
NEWMAN, NJ
机构
[1] EMORY UNIV, SCH MED, DEPT OPHTHALMOL, ATLANTA, GA 30322 USA
[2] EMORY UNIV, SCH MED, DEPT NEUROL, ATLANTA, GA 30322 USA
[3] EMORY UNIV, SCH MED, DEPT NEUROSURG, ATLANTA, GA 30322 USA
关键词
D O I
10.1001/archneur.1993.00540050082021
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective.-Leber's hereditary optic neuropathy (LHON) is a maternally inherited disease that causes bilateral central visual loss, predominantly in young men. Recently, this disorder has been associated with point mutations in the mitochondrial genome. The clinical characteristics of LHON are reviewed with special attention to recent advances in mitochondrial genetics. Data Sources.-Literature from the mid-19th century to the present is reviewed. Study Selection.-Major review articles that include multiple large pedigrees in their analysis are featured. Special emphasis is placed on the recent reports on mitochondrial DNA abnormalities associated with this disease. Data Extraction.-The older literature is reviewed critically with an understanding that some of the patients included as examples of LHON may have had a different disease. The more current references are assessed in regard to their inclusion of appropriate and complete mitochondrial DNA analysis. Data Synthesis.-Leber's hereditary optic neuropathy, a maternally inherited disease primarily of young men, results in bilateral, acute or subacute, central visual loss and, ultimately, optic atrophy. Point mutations in the mitochondrial genes encoding proteins essential to oxidative phosphorylation have been associated with this disorder. Primary mutations include those found at positions 11 778, 3460, and, possibly, 15257 and 14484. Mitochondrial, nuclear, and environmental factors may modify phenotypic expression. Conclusion.-Genetic analysis has allowed for a broader view of what constitutes the clinical phenotype of LHON.
引用
收藏
页码:540 / 548
页数:9
相关论文
共 130 条
[1]   FURTHER CLINICAL AND PATHOLOGICAL OBSERVATIONS ON LEBERS OPTIC ATROPHY [J].
ADAMS, JH ;
BLACKWOOD, W ;
WILSON, J .
BRAIN, 1966, 89 :15-+
[2]  
ASSEMAN R, 1958, THESIS U LILLE LILLE
[3]  
BELL J, 1931, TREASURY HUMAN INH 4, V2
[4]  
BEREDAY M, 1952, AMA ARCH OPHTHALMOL, V48, P669
[5]   LEBERS HEREDITARY OPTIC ATROPHY - FURTHER EVIDENCE FOR A DEFECT OF CYANIDE METABOLISM [J].
BERNINGER, TA ;
VONMEYER, L ;
SIESS, E ;
SCHON, O ;
GOEBEL, FD .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1989, 73 (04) :314-316
[6]  
BIRD A, 1949, CAN MED ASSOC J, V61, P376
[7]   RAPID SHIFT IN GENOTYPE OF HUMAN MITOCHONDRIAL-DNA IN A FAMILY WITH LEBER HEREDITARY OPTIC NEUROPATHY [J].
BOLHUIS, PA ;
BLEEKERWAGEMAKERS, EM ;
PONNE, NJ ;
VANSCHOONEVELD, MJ ;
WESTERVELD, A ;
VANDENBOGERT, C ;
TABAK, HF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 170 (03) :994-997
[8]   CARDIAC-ARRHYTHMIA AND LEBER HEREDITARY OPTIC NEUROPATHY [J].
BOWER, SPC ;
HAWLEY, I ;
MACKEY, DA .
LANCET, 1992, 339 (8806) :1427-1428
[9]   UBIDECARENONE IN THE TREATMENT OF MITOCHONDRIAL MYOPATHIES - A MULTICENTER DOUBLE-BLIND TRIAL [J].
BRESOLIN, N ;
DORIGUZZI, C ;
PONZETTO, C ;
ANGELINI, C ;
MORONI, I ;
CASTELLI, E ;
COSSUTTA, E ;
BINDA, A ;
GALLANTI, A ;
GABELLINI, S ;
PICCOLO, G ;
MARTINUZZI, A ;
CIAFALONI, E ;
ARNAUDO, E ;
LICIARDELLO, L ;
CARENZI, A ;
SCARLATO, G .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1990, 100 (1-2) :70-78
[10]   CLINICAL AND BIOCHEMICAL CORRELATIONS IN MITOCHONDRIAL MYOPATHIES TREATED WITH COENZYME-Q10 [J].
BRESOLIN, N ;
BET, L ;
BINDA, A ;
MOGGIO, M ;
COMI, G ;
NADOR, F ;
FERRANTE, C ;
CARENZI, A ;
SCARLATO, G .
NEUROLOGY, 1988, 38 (06) :892-899